TESTOLACTONE.FLOREY K.1976; ANAL. PROFILES DRUG SUBSTANCES; U.S.A.; DA. 1976; VOL. 5; PP. 533-553; BIBL. 2 P. 1/2Article

COMPARISON OF TESTOSTERONE DECANOATE, DROSTANOLONE AND TESTOLOLACTONE IN DISSEMINATED BREAST CANCER, A RANDOMIZEDCLINICAL STUDY. = UNE COMPARAISON ENTRE LE DECANOATE DE TESTOSTERONE, LA DROSTANOLONE ET LA TESTOLOLACTONE DANS LE CANCER DU SEIN DISSEMINE, UNE ETUDE CLINIQUERIECHE K; WOLFF G.1975; ARCH. GESCHW.-FORSCH.; DTSCH.; DA. 1975; VOL. 45; NO 5; PP. 485-488; ABS. ALLEM.; BIBL. 14 REF.Article

Additive effects of aminoglutethimide, testololactone, and 4-hydroxyandrostenedione as inhibitors of aromataseSANTNER, S. J; ROSEN, H; OSAWA, Y et al.Journal of steroid biochemistry. 1984, Vol 20, Num 6A, pp 1239-1242, issn 0022-4731Article

COMBINED ANDROGEN AND ANTIMETABOLITE THERAPY OF ADVANCED FEMALE BREAST CANCER. A REPORT OF THE COOPERATIVE BREAST CANCER GROUP.GOLDENBERG IS; SEDRANSK N; VOLK H et al.1975; CANCER; U.S.A.; DA. 1975; VOL. 36; NO 2; PP. 308-310; BIBL. 3 REF.Article

EFFECT OF DIBUTYRYL ADENOSINE CYCLIC 3PRIME ,5PRIME -MONOPHOSPHATE AND TESTOLOLACTONE ON CONCANAVALIN A BINDING AND CELL KILLING = EFFETS DU DIBUTYRYL ADENOSINE 3PRIME ,5PRIME -MONOSPHOSPHATE CYCLIQUE ET DE LA TESTOLACTONE SUR LA FIXATION DE LA CONCANAVALINE A ET SES EFFETS CELLULOCIDESSTORRIE B.1974; J. CELL BIOL.; U.S.A.; DA. 1974; VOL. 62; NO 1; PP. 247-252; BIBL. 16REF.Article

TREATMENT OF INTRA-ABDOMINAL AND ABDOMINAL WALL DESMOID TUMORS WITH DRUGS THAT EFFECT THE METABOLISM OF CYCLIC 3PRIME ,5PRIME -ADENOSINE MONOPHOSPHATE = TRAITEMENT DES TUMEURS DESMOIDES DE LA PAROI ABDOMINALE ET INTRA-ABDOMINALE PAR DES SUBSTANCES QUI AGISSENT SUR LE METABOLISME DE L'AMP CYCLIQUEWADDELL WR.1975; ANN. SURG.; U.S.A.; DA. 1975; VOL. 181; NO 3; PP. 299-302; BIBL. 1P.Article

Biotransformation of progesterone by the green alga Chlorella emersonii C211-8HDELLA GRECA, M; FIORENTINO, A; PINTO, G et al.Phytochemistry. 1996, Vol 41, Num 6, pp 1527-1529, issn 0031-9422Article

INHIBITION OF PERIPHERAL AROMATIZATION OF ANDROSTENEDIONE TO ESTRONE IN POSTMENOPAUSAL WOMEN WITH BREAST CANCER USING DELTA ¹-TESTOLOLACTONEBARONE RM; SHAMONKI IM; SIITERI PK et al.1979; J. CLIN. ENDOCRINOL. METABOL.; USA; DA. 1979; VOL. 49; NO 5; PP. 672-676; BIBL. 34 REF.Article

INHIBITION OF ESTROGEN SYNTHESIS IN HUMAN BREAST TUMORS BY TESTOLOLACTONE AND BROMOANDROSTENEDIONEBUDNICK RM; DAO TL.1980; STEROIDS; USA; DA. 1980; VOL. 35; NO 5; PP. 533-541; BIBL. 15 REF.Article

ZUR ANDROGENTHERAPIE DES INKURABLEN MAMMAKARZINOMS KONTROLLIERTER KLINISCHER VERSUCH: NANDROLON - TESTOLOLAKTON - DROSTANOLON = TRAITEMENT PAR LES ANDROGENES DE TUMEURS INCURABLES DE LA GLANDE MAMMAIRE. ESSAI AVEC: NANDROLONE - TESTOLOLACTONE ET DROSTANOLONEWOLFF G; RIECHE K.1978; ONKOLOGIE; DEU; DA. 1978; VOL. 1; NO 4; PP. 172-174; ABS. ENG; BIBL. 11 REF.Article

First generation aromatase inhibitors : aminoglutethimide and testololactoneCOCCONI, G.Breast cancer research and treatment. 1994, Vol 30, Num 1, pp 57-80, issn 0167-6806Article